Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (495)	8/1/2008 1:44:35 PM
From: tuck	Read Replies (1) \| Respond to of 588

Technically, a confirmed breakdown. Target in $2.70 area, in theory. Doesn't mean we get there. I have added at $3. Cheers, Tuck

To: scaram(o)uche who wrote (495)	8/1/2008 1:52:26 PM
From: Ian@SI	Read Replies (1) \| Respond to of 588

If it's Aberdeen, they sold their last share by or before their report date of 07/30 (Wednesday). Of those reporting activity in July, a quick eyeball of the stats shows that the poorest performing funds sold ACAD; while the best performing funds added. mffais.com In any case, all this is looking in the rear view mirror. I'd much rather know what the funds are planning to do during the next couple months. ;-)